CD4 and AIDS: Both were based on data from the HIV-CAUSAL collaboration (21) of cohorts in Europe and the United States, for which sample size is large; they found a slightly lower risk of AIDS progression among patients beginning treatment at CD4+ T-cell counts of ≥500 cells/mm3 compared to those with deferred treatment.